p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated Apoptosis
暂无分享,去创建一个
[1] R. Summers,et al. Desensitization and resensitization of β1‐ and putative β4‐adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure , 1999 .
[2] Catherine Communal,et al. Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein , 1999 .
[3] R Aikawa,et al. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. , 1999, Circulation.
[4] S. Husain,et al. Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholipase A2 in cat iris sphincter smooth muscle cells. , 1999, The Biochemical journal.
[5] S. Sasayama,et al. α- and β-Adrenergic Pathways Differentially Regulate Cell Type–Specific Apoptosis in Rat Cardiac Myocytes , 1999 .
[6] J. Testa,et al. Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival , 1999, Molecular and Cellular Biology.
[7] D. Mochly‐Rosen,et al. An Inhibitor of p38 Mitogen-activated Protein Kinase Protects Neonatal Cardiac Myocytes from Ischemia* , 1999, The Journal of Biological Chemistry.
[8] K. Webster,et al. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. , 1999, Circulation research.
[9] E. Lakatta,et al. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. , 1999, Circulation research.
[10] R. Hajjar,et al. Signaling pathways mediating the response to hypertrophic stress in the heart. , 1999, Gene expression.
[11] D. Pimentel,et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. , 1998, Circulation.
[12] A. Clerk,et al. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. , 1998, Circulation research.
[13] A. Katz,et al. Regression of left ventricular hypertrophy: new hope for dying hearts. , 1998, Circulation.
[14] A. Clerk,et al. Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy? , 1998, The Journal of cell biology.
[15] Shuang Huang,et al. Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.
[16] Hsien-yu Wang,et al. Conditional, Tissue-specific Expression of Q205L Gαi2 in Vivo Mimics Insulin Activation of c-Jun N-terminal Kinase and p38 Kinase* , 1998, The Journal of Biological Chemistry.
[17] D. Zechner,et al. MKK6 Activates Myocardial Cell NF-κB and Inhibits Apoptosis in a p38 Mitogen-activated Protein Kinase-dependent Manner* , 1998, The Journal of Biological Chemistry.
[18] Jiahuai Han,et al. Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.
[19] J Ross,et al. Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.
[20] J. Bonventre,et al. Growth factors and mitogen-activated protein kinases. , 1998, Hypertension.
[21] Yong Jiang,et al. Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ* , 1997, The Journal of Biological Chemistry.
[22] Robert J. Lefkowitz,et al. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.
[23] J C Lee,et al. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. , 1997, Biochemical and biophysical research communications.
[24] M. Su,et al. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors , 1997, Molecular and cellular biology.
[25] K. Chien,et al. Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.
[26] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[27] R. Virmani,et al. Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.
[28] W. Colucci. Apoptosis in the heart. , 1996, The New England journal of medicine.
[29] P. Mehlen,et al. Human hsp27, Drosophila hsp27 and human alphaB‐crystallin expression‐mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha‐induced cell death. , 1996, The EMBO journal.
[30] P. Anversa,et al. Myocyte death in heart failure. , 1996, Current opinion in cardiology.
[31] A. Clerk,et al. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. , 1996, The Biochemical journal.
[32] J. Balligand,et al. Regulation of Cytokine-inducible Nitric Oxide Synthase in Cardiac Myocytes and Microvascular Endothelial Cells , 1996, The Journal of Biological Chemistry.
[33] J. Balligand,et al. Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial Cells , 1995, The Journal of Biological Chemistry.
[34] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[35] P. Crespo,et al. Dual Effect of β-Adrenergic Receptors on Mitogen-activated Protein Kinase , 1995, The Journal of Biological Chemistry.
[36] R. Lefkowitz,et al. Distinct Pathways of G- and G-mediated Mitogen-activated Protein Kinase Activation (*) , 1995, The Journal of Biological Chemistry.
[37] E. Lakatta,et al. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. , 1995, Molecular pharmacology.
[38] R. Lefkowitz,et al. Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Crespo,et al. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits , 1994, Nature.
[40] H. Bourne,et al. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. , 1994, The Journal of biological chemistry.
[41] J. Parratt. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. , 1994, Trends in pharmacological sciences.
[42] H. Snow,et al. THE CARDIOVASCULAR EFFECTS OF ICI 118,587: A β1‐ADRENOCEPTOR PARTIAL AGONIST , 1982 .